These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D. Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792 [Abstract] [Full Text] [Related]
23. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G. J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490 [Abstract] [Full Text] [Related]
24. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath H. J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032 [Abstract] [Full Text] [Related]
25. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension. Fardella C, Rodriguez-Portales JA. J Endocrinol Invest; 1995 Dec; 18(11):827-32. PubMed ID: 8778153 [Abstract] [Full Text] [Related]
26. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. Hackeng WH, Lips P, Netelenbos JC, Lips CJ. J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025 [Abstract] [Full Text] [Related]
27. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801 [Abstract] [Full Text] [Related]
29. Effects of parathyroid hormone infusion and primary hyperparathyroidism on serum prolactin in man. Castro JH, Caro JF, Kim HJ, Glennon JA. J Clin Endocrinol Metab; 1980 Aug; 51(2):397-8. PubMed ID: 7400304 [Abstract] [Full Text] [Related]
30. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology. Niedźwiecki S, Kuzdak K, Kaczka K, Pomorski L. Wiad Lek; 2007 Aug; 60(5-6):228-30. PubMed ID: 17966885 [Abstract] [Full Text] [Related]
31. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Minisola S, D' Erasmo E, Mazzuoli GF, Letizia C. Metabolism; 2007 Jan; 56(1):30-6. PubMed ID: 17161223 [Abstract] [Full Text] [Related]
32. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. Lundgren E, Hagström EG, Lundin J, Winnerbäck K, Roos J, Ljunghall S, Rastad J. World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863 [Abstract] [Full Text] [Related]
33. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. Ramirez JA, Goodman WG, Gornbein J, Menezes C, Moulton L, Segre GV, Salusky IB. J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155 [Abstract] [Full Text] [Related]
34. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Glendenning P, Gutteridge DH, Retallack RW, Stuckey BG, Kermode DG, Kent GN. Aust N Z J Med; 1998 Apr; 28(2):173-8. PubMed ID: 9612524 [Abstract] [Full Text] [Related]
35. Effects of an inhaled β2-agonist on cardiovascular function and sympathetic activity in healthy subjects. Snyder EM, Wong EC, Foxx-Lupo WT, Wheatley CM, Cassuto NA, Patanwala AE. Pharmacotherapy; 2011 Aug; 31(8):748-56. PubMed ID: 21923601 [Abstract] [Full Text] [Related]
36. Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. Curione M, Amato S, Di Bona S, Petramala L, Cotesta D, Letizia C. Int J Cardiol; 2010 May 28; 141(2):201-2. PubMed ID: 19346020 [Abstract] [Full Text] [Related]
37. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. Peacock M, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D. J Clin Endocrinol Metab; 2009 Dec 28; 94(12):4860-7. PubMed ID: 19837909 [Abstract] [Full Text] [Related]
38. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism. Osterode W, Winker R, Bieglmayer C, Vierhapper H. Bone; 2004 Oct 28; 35(4):942-7. PubMed ID: 15454101 [Abstract] [Full Text] [Related]
39. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Yen TW, Wilson SD, Krzywda EA, Sugg SL. Surgery; 2006 Oct 28; 140(4):665-72; discussion 672-4. PubMed ID: 17011915 [Abstract] [Full Text] [Related]
40. [Prospective study on incidence of primary hyperparathyroidism in patients with goiter]. Niedźwiecki S, Kuzdak K, Kaczka K, Pomorski L. Pol Merkur Lekarski; 2006 Nov 28; 21(125):469-73. PubMed ID: 17345842 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]